some present cure for any certified indicator that falls outside of Good recommendations e.g. to be a 1st line treatment method when NICE only recommends right after other procedure selections have been tried out or for dose escalation which may well not are assessed as becoming cost efficient by NICE.the medicine or issue is currently commissioned